IMGO IPOs 9.66M* shares @$16.00: https://www.businesswire.com/news/home/20210715006139/en Imago BioSciences, Inc. [is] a clinical stage biopharmaceutical company discovering new medicines for the treatment of myeloproliferative neoplasm’s… *Assuming exercise of underwriter’s option.